ExodusPoint Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,952
Closed -$1.79M 1651
2025
Q1
$1.79M Buy
9,952
+191
+2% +$34.4K 0.02% 679
2024
Q4
$1.53M Buy
+9,761
New +$1.53M 0.01% 746
2024
Q3
Sell
-14,892
Closed -$2.74M 1728
2024
Q2
$2.74M Sell
14,892
-3,380
-18% -$621K 0.02% 565
2024
Q1
$3.25M Sell
18,272
-24,230
-57% -$4.31M 0.02% 441
2023
Q4
$5.27M Buy
42,502
+14,752
+53% +$1.83M 0.03% 298
2023
Q3
$3.22M Buy
27,750
+3,649
+15% +$423K 0.03% 469
2023
Q2
$2.83M Sell
24,101
-112,040
-82% -$13.2M 0.02% 595
2023
Q1
$10.9M Buy
136,141
+30,380
+29% +$2.43M 0.09% 200
2022
Q4
$8.38M Buy
105,761
+40,975
+63% +$3.25M 0.12% 202
2022
Q3
$4.52M Buy
64,786
+43,720
+208% +$3.05M 0.06% 413
2022
Q2
$1.38M Buy
+21,066
New +$1.38M 0.02% 898
2019
Q2
Sell
-17,648
Closed -$581K 1206
2019
Q1
$581K Buy
+17,648
New +$581K 0.04% 282